nucare limited
nucare limited Company Information
Company Number
02821239
Website
http://myp-i-n.co.ukRegistered Address
phoenix rivington road, preston brook, runcorn, cheshire, WA7 3DJ
Industry
Wholesale of pharmaceutical goods
Telephone
448007833909
Next Accounts Due
October 2024
Group Structure
View All
Shareholders
phoenix medical supplies ltd 100%
nucare limited Estimated Valuation
Pomanda estimates the enterprise value of NUCARE LIMITED at £5.2m based on a Turnover of £10.1m and 0.51x industry multiple (adjusted for size and gross margin).
nucare limited Estimated Valuation
Pomanda estimates the enterprise value of NUCARE LIMITED at £0 based on an EBITDA of £-873k and a 4.01x industry multiple (adjusted for size and gross margin).
nucare limited Estimated Valuation
Pomanda estimates the enterprise value of NUCARE LIMITED at £0 based on Net Assets of £-2.2m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nucare Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Nucare Limited Overview
Nucare Limited is a live company located in runcorn, WA7 3DJ with a Companies House number of 02821239. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 1993, it's largest shareholder is phoenix medical supplies ltd with a 100% stake. Nucare Limited is a mature, mid sized company, Pomanda has estimated its turnover at £10.1m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Nucare Limited Health Check
Pomanda's financial health check has awarded Nucare Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 8 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
8 Weak
Size
annual sales of £10.1m, make it smaller than the average company (£24.1m)
£10.1m - Nucare Limited
£24.1m - Industry AVG
Growth
3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (5%)
-2% - Nucare Limited
5% - Industry AVG
Production
with a gross margin of 9.9%, this company has a higher cost of product (23.1%)
9.9% - Nucare Limited
23.1% - Industry AVG
Profitability
an operating margin of -14.7% make it less profitable than the average company (3.6%)
-14.7% - Nucare Limited
3.6% - Industry AVG
Employees
with 31 employees, this is similar to the industry average (37)
31 - Nucare Limited
37 - Industry AVG
Pay Structure
on an average salary of £21.6k, the company has a lower pay structure (£67k)
£21.6k - Nucare Limited
£67k - Industry AVG
Efficiency
resulting in sales per employee of £326.6k, this is less efficient (£594k)
£326.6k - Nucare Limited
£594k - Industry AVG
Debtor Days
it gets paid by customers after 73 days, this is later than average (59 days)
73 days - Nucare Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 22 days, this is quicker than average (30 days)
22 days - Nucare Limited
30 days - Industry AVG
Stock Days
it holds stock equivalent to 20 days, this is less than average (57 days)
20 days - Nucare Limited
57 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Nucare Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 170.7%, this is a higher level of debt than the average (57.1%)
170.7% - Nucare Limited
57.1% - Industry AVG
nucare limited Credit Report and Business Information
Nucare Limited Competitor Analysis
Perform a competitor analysis for nucare limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
nucare limited Ownership
NUCARE LIMITED group structure
Nucare Limited has no subsidiary companies.
Ultimate parent company
PHOENIX PHARMA SE
#0058113
2 parents
NUCARE LIMITED
02821239
nucare limited directors
Nucare Limited currently has 2 directors. The longest serving directors include Mr Stephen Anderson (Oct 2017) and Mr Jonathan Fearn (Feb 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Stephen Anderson | England | 57 years | Oct 2017 | - | Director |
| Mr Jonathan Fearn | England | 50 years | Feb 2024 | - | Director |
NUCARE LIMITED financials
Nucare Limited's latest turnover from January 2023 is £10.1 million and the company has net assets of -£2.2 million. According to their latest financial statements, Nucare Limited has 31 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10,124,000 | 11,536,000 | 10,623,000 | 10,820,000 | 9,069,000 | 7,428,000 | 4,962,000 | 186,000 | ||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cost Of Sales | 9,121,000 | 10,390,000 | 9,513,000 | 9,425,000 | 8,055,000 | 6,544,000 | 4,282,000 | 126,000 | ||||||
| Gross Profit | 1,003,000 | 1,146,000 | 1,110,000 | 1,395,000 | 1,014,000 | 884,000 | 680,000 | 60,000 | ||||||
| Admin Expenses | 2,492,000 | 1,184,000 | 1,068,000 | 1,057,000 | 1,221,000 | 1,200,000 | 1,234,000 | 376,000 | ||||||
| Operating Profit | -1,489,000 | -38,000 | 42,000 | 338,000 | -207,000 | -316,000 | -554,000 | -316,000 | ||||||
| Interest Payable | 13,000 | 14,000 | 15,000 | 16,000 | 0 | 0 | 0 | 0 | ||||||
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Pre-Tax Profit | -1,502,000 | -52,000 | 27,000 | 322,000 | -207,000 | -316,000 | -554,000 | -316,000 | ||||||
| Tax | 261,000 | -22,000 | 14,000 | -67,000 | 31,000 | 57,000 | 101,000 | 62,000 | ||||||
| Profit After Tax | -1,241,000 | -74,000 | 41,000 | 255,000 | -176,000 | -259,000 | -453,000 | -254,000 | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Profit | -1,241,000 | -74,000 | 41,000 | 255,000 | -176,000 | -259,000 | -453,000 | -254,000 | ||||||
| Employee Costs | 669,000 | 607,000 | 560,000 | 580,000 | 630,000 | 636,000 | 525,000 | 217,000 | ||||||
| Number Of Employees | 31 | 26 | 26 | 26 | 26 | 27 | 20 | 7 | ||||||
| EBITDA* | -873,000 | 51,000 | 143,000 | 451,000 | -112,000 | -220,000 | -472,000 | -284,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 180,000 | 786,000 | 858,000 | 954,000 | 491,000 | 553,000 | 583,000 | 603,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 850,000 | 850,000 | 852,000 | 863,000 | 893,000 | 907,000 | 903,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 180,000 | 1,636,000 | 1,708,000 | 1,806,000 | 1,354,000 | 1,446,000 | 1,490,000 | 1,506,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 520,000 | 522,000 | 468,000 | 567,000 | 605,000 | 444,000 | 220,000 | 134,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 2,050,000 | 2,271,000 | 2,082,000 | 1,601,000 | 1,942,000 | 1,411,000 | 981,000 | 177,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 319,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 312,000 | 43,000 | 370,000 | 255,000 | 44,000 | 33,000 | 157,000 | 100,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,882,000 | 2,836,000 | 2,920,000 | 2,423,000 | 2,591,000 | 1,889,000 | 1,677,000 | 411,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total assets | 3,062,000 | 4,472,000 | 4,628,000 | 4,229,000 | 3,945,000 | 3,335,000 | 3,167,000 | 1,917,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 112,000 | 59,000 | 0 | 0 | 0 | 2,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 571,000 | 585,000 | 572,000 | 412,000 | 463,000 | 168,000 | 19,000 | 8,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 4,126,000 | 4,121,000 | 4,246,000 | 4,056,000 | 4,529,000 | 4,029,000 | 3,753,000 | 2,091,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 29,000 | 29,000 | 32,000 | 46,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 96,000 | 229,000 | 53,000 | 70,000 | 92,000 | 94,000 | 94,000 | 62,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 4,822,000 | 4,964,000 | 5,015,000 | 4,643,000 | 5,084,000 | 4,291,000 | 3,866,000 | 2,163,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 399,000 | 428,000 | 457,000 | 471,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 6,000 | 4,000 | 6,000 | 6,000 | 7,000 | 10,000 | 8,000 | 8,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 405,000 | 432,000 | 463,000 | 477,000 | 7,000 | 10,000 | 8,000 | 8,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 5,227,000 | 5,396,000 | 5,478,000 | 5,120,000 | 5,091,000 | 4,301,000 | 3,874,000 | 2,171,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | -2,165,000 | -924,000 | -850,000 | -891,000 | -1,146,000 | -966,000 | -707,000 | -254,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| total shareholders funds | -2,165,000 | -924,000 | -850,000 | -891,000 | -1,146,000 | -966,000 | -707,000 | -254,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -1,489,000 | -38,000 | 42,000 | 338,000 | -207,000 | -316,000 | -554,000 | -316,000 | ||||||
| Depreciation | 616,000 | 89,000 | 99,000 | 102,000 | 65,000 | 60,000 | 54,000 | 24,000 | ||||||
| Amortisation | 0 | 0 | 2,000 | 11,000 | 30,000 | 36,000 | 28,000 | 8,000 | ||||||
| Tax | 261,000 | -22,000 | 14,000 | -67,000 | 31,000 | 57,000 | 101,000 | 62,000 | ||||||
| Stock | -2,000 | 54,000 | -99,000 | -38,000 | 161,000 | 224,000 | 86,000 | 134,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 48,000 | -138,000 | 596,000 | -130,000 | 542,000 | -13,000 | 1,180,000 | 277,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | -14,000 | 13,000 | 160,000 | -51,000 | 295,000 | 149,000 | 11,000 | 8,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | -133,000 | 176,000 | -17,000 | -22,000 | -2,000 | 0 | 32,000 | 62,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 2,000 | -2,000 | 0 | -1,000 | -3,000 | 2,000 | 0 | 8,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -803,000 | 300,000 | -197,000 | 478,000 | -494,000 | -223,000 | -1,594,000 | -555,000 | ||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 5,000 | -125,000 | 190,000 | -473,000 | 500,000 | 276,000 | 1,662,000 | 2,091,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -29,000 | -29,000 | -14,000 | 471,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | -3,000 | -14,000 | 46,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -13,000 | -14,000 | -15,000 | -16,000 | 0 | 0 | 0 | 0 | ||||||
| cash flow from financing | -37,000 | -171,000 | 147,000 | 28,000 | 496,000 | 276,000 | 1,662,000 | 2,091,000 | ||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | -1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | -112,000 | 53,000 | 59,000 | 0 | 0 | -2,000 | 2,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 112,000 | -53,000 | -59,000 | -1,000 | 1,000 | 2,000 | -2,000 | 0 | 0 | 0 | 0 | 0 | 0 |
P&L
January 2023turnover
10.1m
-12%
operating profit
-1.5m
+3818%
gross margin
10%
-0.27%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2023net assets
-2.2m
+1.34%
total assets
3.1m
-0.32%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
nucare limited company details
company number
02821239
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
May 1993
age
31
accounts
Full Accounts
ultimate parent company
previous names
nucare plc (February 2008)
incorporated
UK
address
phoenix rivington road, preston brook, runcorn, cheshire, WA7 3DJ
last accounts submitted
January 2023
nucare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to nucare limited. Currently there are 0 open charges and 2 have been satisfied in the past.
nucare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
